- Trials with a EudraCT protocol (245)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
245 result(s) found for: Hospital Anxiety and Depression Scale.
Displaying page 1 of 13.
EudraCT Number: 2012-000438-21 | Sponsor Protocol Number: 750201.01.035 | Start Date*: 2012-10-17 | |||||||||||
Sponsor Name:Dr. Willmar Schwabe GmbH & Co. KG | |||||||||||||
Full Title: Multi-center, double-blind, placebo-controlled, randomized phase III study to prove the efficacy, safety and tolerability of Silexan (WS®1265) in patients with mixed anxiety and depressive disorder... | |||||||||||||
Medical condition: mixed anxiety and depressive disorder (ICD-10, F41.2) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-001666-15 | Sponsor Protocol Number: CL3-20098-087 | Start Date*: 2013-06-11 | |||||||||||
Sponsor Name:Institut de Recherches Internationales Servier | |||||||||||||
Full Title: Efficacy and safety of 2 doses of agomelatine (10 mg/day or 25 mg/day) versus placebo given orally for 12 weeks in non depressed out-patients with Generalized Anxiety Disorder. A 12-week randomise... | |||||||||||||
Medical condition: Generalized Anxiety Disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) SK (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-002116-32 | Sponsor Protocol Number: MTM-04 | Start Date*: 2015-09-23 | ||||||||||||||||||||||||||
Sponsor Name:Køge Hospital | ||||||||||||||||||||||||||||
Full Title: The effect of MElatonin on Depression, Anxiety, CIrcadian and Sleep disturbances in patients after acute myocardial syndrome | ||||||||||||||||||||||||||||
Medical condition: Depression Anxiety Sleep disturbances Circadian disturbances | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2004-004960-64 | Sponsor Protocol Number: F1J-MC-HMDW(b) | Start Date*: 2005-05-13 |
Sponsor Name:Eli Lilly and Company Limited | ||
Full Title: A Comparison of Duloxetine Hydrochloride, Venlafaxine Extended Release, and Placebo in the Treatment of Generalized Anxiety Disorder | ||
Medical condition: Generalised Anxiety Disorder | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2004-002482-20 | Sponsor Protocol Number: NUMACT 1 | Start Date*: 2005-12-02 |
Sponsor Name:Newcastle upon Tyne Hospitals NHS Trust | ||
Full Title: A Pilot Study to Test the Effect of Treating Depression Associated with Rueumatoid Arthritis (RA) using Venlaflaxine | ||
Medical condition: Symptoms of Depression as defined by the Hospital Anxiety and Depression Questionnaire associated with Rheumatoid Arthritis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2010-024632-42 | Sponsor Protocol Number: H9P-MC-LNBN | Start Date*: 2011-05-05 | |||||||||||
Sponsor Name:Eli Lilly and Company | |||||||||||||
Full Title: LY2216684 compared to Placebo as Adjunctive Therapy to SSRI in the Prevention of Symptom Re-emergence in Major Depressive Disorder | |||||||||||||
Medical condition: major depressive disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) BE (Completed) SK (Completed) GR (Completed) ES (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-019369-27 | Sponsor Protocol Number: ANX001-01 | Start Date*: 2010-07-23 | |||||||||||
Sponsor Name:Anxiofit Ltd. | |||||||||||||
Full Title: A Phase II randomized, double-blind, parallel-group, multi-site, placebo controlled fixed-dose study of Echinaceae angustifoliae root dry extract in 24 outpatients with generalized anxiety disorder... | |||||||||||||
Medical condition: Generalized Anxiety Disorder (GAD) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-001325-27 | Sponsor Protocol Number: 18314A | Start Date*: 2019-12-26 | |||||||||||
Sponsor Name:H. Lundbeck A/S | |||||||||||||
Full Title: Interventional, open-label effectiveness study of flexible doses of vortioxetine on depressive symptoms in patients with major depressive disorder comorbid with generalized anxiety disorder | |||||||||||||
Medical condition: Depressive symptoms in patients with major depressive disorder (MDD) comorbid with generalized anxiety disorder (GAD) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-004442-11 | Sponsor Protocol Number: JAZ-01 | Start Date*: 2020-12-01 | |||||||||||
Sponsor Name:Zealand University Hospital | |||||||||||||
Full Title: The effect of Melatonin in patients with Low Anterior Resection Syndrome | |||||||||||||
Medical condition: Low anterior resection syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-001766-90 | Sponsor Protocol Number: LuAA21004_311 | Start Date*: 2009-04-09 | |||||||||||
Sponsor Name:Takeda Global Research & Development Centre (Europe) Ltd. | |||||||||||||
Full Title: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed-Dose Study Comparing the Efficacy and Safety of a Single Dose of Lu AA21004 in Acute Treatment of Adults With Generalized Anxie... | |||||||||||||
Medical condition: Generalized Anxiety Disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) DE (Completed) LV (Completed) EE (Completed) LT (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-002787-32 | Sponsor Protocol Number: RG_19-172 | Start Date*: 2020-11-16 |
Sponsor Name:University of Birmingham | ||
Full Title: Antidepressant for the prevention of DEPression following first episode Psychosis trial | ||
Medical condition: Patients with First Episode Psychosis. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2019-001621-27 | Sponsor Protocol Number: 201900242 | Start Date*: 2021-02-24 |
Sponsor Name:University Medical Center Groningen | ||
Full Title: A pilot study on oral s-ketamine for depression and demoralization in patients with advanced cancer receiving palliative care | ||
Medical condition: Major depressive disorder | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-005149-64 | Sponsor Protocol Number: MIN-117C03 | Start Date*: 2018-05-23 | |||||||||||
Sponsor Name:Minerva Neurosciences, Inc | |||||||||||||
Full Title: A Randomized, Double-Blind, Parallel-Group, Placebo Controlled Study to Evaluate the Efficacy and Safety of 2 Fixed Doses (5.0 mg or 2.5 mg) of MIN-117 in Adult Patients with Major Depressive Disorder | |||||||||||||
Medical condition: Major Depressive Disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) PL (Completed) BG (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-015165-31 | Sponsor Protocol Number: EME-08/43/39 | Start Date*: 2010-07-16 |
Sponsor Name:Northumberland, Tyne and Wear NHS Foundation Trust | ||
Full Title: Antiglucocorticoid augmentation of antiDepressants in Depression: a double-blind, randomised, placebo-controlled, parallel-group trial | ||
Medical condition: depression | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2018-002942-35 | Sponsor Protocol Number: CTU/2017/285 | Start Date*: 2019-10-31 | ||||||||||||||||
Sponsor Name:University College London Comprehensive Clinical Trials Unit | ||||||||||||||||||
Full Title: A Randomised Controlled Trial of Escitalopram and Nortriptyline compared with placebo and standard psychological care for depression in Parkinson’s Disease | ||||||||||||||||||
Medical condition: Depression in Parkinson's disease | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-005457-25 | Sponsor Protocol Number: PCN-101-21 | Start Date*: 2021-08-30 | |||||||||||
Sponsor Name:Perception Neuroscience, Inc | |||||||||||||
Full Title: A randomized, placebo-controlled, double-blind study to assess the safety and efficacy of intravenous PCN-101 in treatment-resistant depression | |||||||||||||
Medical condition: Treatment-resistant depression | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) PL (Completed) IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-002626-22 | Sponsor Protocol Number: F1J-MC-HMDV(a) | Start Date*: 2005-01-24 |
Sponsor Name:Eli Lilly and Company Limited | ||
Full Title: Duloxetine 60 to 120 mg Once Daily Compared with Placebo in the Prevention of Relapse in Generalized Anxiety Disorder | ||
Medical condition: Generalized Anxiety Disorder | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-003867-13 | Sponsor Protocol Number: CL2-47445-014 | Start Date*: 2016-02-15 | |||||||||||
Sponsor Name:Institut de Recherches internationales Servier | |||||||||||||
Full Title: Efficacy and safety of S 47445 versus placebo as adjunctive treatment of Major Depressive Disorder in patients with an inadequate response to antidepressant therapy. A randomised, double-blind, pla... | |||||||||||||
Medical condition: Major depressive disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) FI (Completed) SK (Completed) CZ (Completed) BG (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-005164-26 | Sponsor Protocol Number: DS5565-A-E312 | Start Date*: 2014-12-19 | |||||||||||
Sponsor Name:Daiichi Sankyo Inc. | |||||||||||||
Full Title: An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated with Fibromyalgia | |||||||||||||
Medical condition: DS-5565 is being developed for the treatment of pain associated with fibromyalgia (FM). | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) SE (Completed) DK (Completed) AT (Completed) SK (Completed) EE (Completed) CZ (Completed) ES (Completed) LT (Completed) HU (Completed) LV (Completed) PT (Completed) SI (Completed) FI (Completed) BG (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-004210-26 | Sponsor Protocol Number: 14/0647 | Start Date*: 2016-11-22 | |||||||||||
Sponsor Name:PRIMENT Clinical Trials Unit, UCL | |||||||||||||
Full Title: A Phase IV double blind multi-site, individually randomised parallel group controlled trial investigating the use of citalopram, sertraline, fluoxetine and mirtazapine in preventing relapse in pati... | |||||||||||||
Medical condition: Depression | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
